Holen Sie sich die Stockscreener-App
1.41
0.70%
-0.01
Handel nachbörslich:
1.39
-0.02
-1.42%
Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten
Undervalued Opportunities: Penny Stocks To Watch In September 2026 - simplywall.st
ORGO stock gains on a fresh price snapshot - AD HOC NEWS
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Exploring a Potential 47% Upside in Regenerative Medicine - DirectorsTalk Interviews
Organogenesis (ORGO) Drops 7% to $1.59: Wound Care Specialist Nears Critical SupportPercent Below MA - dars.gov.et
ORGO Q2 2026 Earnings: Significant EPS Miss Highlights Profitability ChallengesDiluted EPS Report - careplusvn.com
Organogenesis stock trades without a fresh catalyst, recent results define the picture - ad-hoc-news.de
Organogenesis (ORGO) Quarter in Focus: Reported EPS Misses Expectations for the Current Session; Closing Reaction - vinanet.vn
ORGO | Organogenesis Holdings Inc. Class FinancialsRevenue Breakdown - Quiver Quantitative
Organogenesis (ORGO) Shares: Moves 2.17% Down to $1.80 in the Latest Session; Chart View - dars.gov.et
Spotlighting Anixa Biosciences And 2 Other Noteworthy Penny Stocks - Sahm
Organogenesis (ORGO) Chart: Moves 3.35% Up to $1.85 on the Day; Current Setup: the Near-Term Reference Band Stretches From $1.76 to $1.94 in Latest TradingRSI Overbought Alerts - vinanet.vn
Organogenesis Holdings Inc (ORGO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript - AOL.com
Oragenics: Q2 Earnings Snapshot - AOL.com
Organogenesis, lured to RI with tax credits, is bleeding money - The Business Journals
OrganiGram: Fiscal Q3 Earnings Snapshot - AOL.com
Organogenesis Holdings, Inc. Class A Revenue Breakdown – MUN:2PQ - TradingView
Organogenesis Holdings (ORGO) Stock Fair Value Moves Lower After Guidance Cut And Analyst Caution - Yahoo Finance
Organogenesis Holdings Inc (ORGO) Stock News Today - TradingKey
Organogenesis Holdings (ORGO) Is Down 21.5% After Slashing 2026 Guidance And Launching Equity Offering – Has The Bull Case Changed? - Yahoo Finance
Organogenesis (NASDAQ:ORGO) Cut to Strong Sell at Wall Street Zen - MarketBeat
Organogenesis Shares Plunge After Revenue Slump, Wider Loss and Lower Outlook - Moomoo
Truist Adjusts Price Target on Organogenesis to $2 From $3, Maintains Hold Rating - marketscreener.com
Truist Financial Has Lowered Expectations for Organogenesis (NASDAQ:ORGO) Stock Price - MarketBeat
Organogenesis Holdings Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower By Investing.com - Investing.com Australia
Form 8K Organogenesis Holdings Inc For: 6 August By Investing.com - Investing.com Nigeria
Organogenesis Holdings enters at-the-market sales agreement for up to $75 million - Investing.com Nigeria
Organogenesis Holdings Inc. (ORGO) Stock Analysis: Potential 24% Upside For Investors - DirectorsTalk Interviews
Organogenesis Q2 Earnings Call Highlights - Yahoo Finance
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results - The Manila Times
Organogenesis earnings missed by $0.42, revenue fell short of estimates - Investing.com Canada
Earnings call transcript: Organogenesis Q2 2026 miss sends shares lower - Investing.com
Transcript : Organogenesis Holdings Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
Organogenesis: Q2 Earnings Snapshot - Barchart.com
Organogenesis Holdings Inc. reports results for the quarter ended June 30Earnings Summary - tradingview.com
ORGO: Q2 2026 revenue plunged 58% and net loss widened sharply amid ongoing market and regulatory challenges - TradingView
Organogenesis (Nasdaq: ORGO) sets up $75M at-the-market stock sale - Stock Titan
Organogenesis Holdings Inc. Q2 2026: Revenue $42.8M, EPS $(0.77) — 10-Q Summary - tradingview.com
Organogenesis (NASDAQ: ORGO) hit by 58% sales drop and $149M first-half loss - Stock Titan
Organogenesis Holdings Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Organogenesis Holdings reports Q2 2026 revenue $42.8M, net loss $96.3M - TradingView
Organogenesis Holdings Inc. Revises Revenue Guidance for the Second Half of the Year Ending December 31, 2026 - marketscreener.com
Organogenesis Holdings, Inc. Class A Revenue Breakdown – LS:A2PA31 - TradingView
ORGO Q2'26 Earnings: EPS estimate is (0.35) USD - TradingView
Organogenesis Holdings Inc. expected to post a loss of 35 cents a shareEarnings Preview - TradingView
ORGO Q1 2026 Earnings: Deep EPS Miss Signals Persistent Profitability PressuresEarnings Quality Score - vinanet.vn
Organon: Q2 Earnings Snapshot - AOL.com
Organogenesis (ORGO) to Release Quarterly Earnings on Thursday - MarketBeat
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - The Manila Times
Organogenesis Holdings Inc (ORGO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Organogenesis reports positive trial results for wound care product By Investing.com - Investing.com South Africa
Organogenesis reports positive trial results for wound care product - Investing.com
Organogenesis Announces Published RCT Results Showing Affinity Plus Standard of Care Improves Closure Rates in Complex Venous Leg Ulcers - Quiver Quantitative
Peer-reviewed Affinity trial finds higher closure in leg wounds over 24 months - Stock Titan
0.18%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):